Search

On Demand

Tags

Plenary
Continuous Manufacturing for Large Molecule
Continuous Manufacturing for Small Molecule
Virtual Networking
Cell & Gene Therapy Sessions
Digitalization Sessions
Drug Products Sessions
Pharma 4.0 Sessions
Plenary Sessions - Bonus Content Included
Quality Control Sessions
Regulatory Harmonization Sessions
Continuous Manufacturing for Large Molecule Sessions
Continuous Manufacturing for Small Molecule Sessions
Factories of the Future: Back-up Manufacturing, Contingency Plans, More Local API Production?
Industry's and Regulators' View on COVID-19: Impact on Industry and Regulation
Quality Management in Crisis Times: Relevant Regulation for Industry, How to Protect Workers and Products
New Trends in CQV and Impact on Project Delivery in Times of Corona Crisis
Information Systems
Innovation Forum
Process Development and Manufacturing
Quality Systems and Regulatory
Supply Chain, Operations, & Packaging Excellence
Facility of the Year (FOYA)
Track 1: Quality and Regulatory
Track 2: Technology Advancement
Track 3: Process and Data Science
Track 4: ATMP and Aseptic Processing
Factories of the Future: Back-up Manufacturing;Contingency
Plenary Session
Factories of the Future: Back up Manufacturing, Contingency Plans, More Local API Production?
Factories of the Future: Back-up Manufacturing;Contingency Plans;More Local API Production?
Keynotes
Plant Tours
Workshops
Networking
Pharma 4.0 Vision - Imagine How Pharma 4.0 Could Look Like
Pharma 4.0 Case Studies
Pharma 4.0 & Regulations
Facilities and Equipment
Poster Presentations
OPENING PLENARY SESSION
Intersection of ATMPs and New Technologies
Contamination and Cross Contamination Control for Bio Safety
Networking Opportunity
Facility Considerations for Next-Generation Sterile Product Manufacturing
Containment: Understanding Why, When, and What Regulatory Agencies Expect
PLENARY SESSION: The revision of EU GMPs Annex 1: What impacts can we expect as an industry?
H2O2: Not the Same old Topic
Modular Robotic Fill/Finish Lines
Single Use Technologies – Are they sustainable
PROCESS SAFETY
Devices and Decontamination—Overcoming Challenges
Regulatory View on ATMPs and Make vs. Buy
INTERACTIVE REGULATORY PANEL: Potential Topic – COVID-19 (Supply Chain, Vaccines, Aseptic)
Keynote
Break
Panel Discussion
Closing
Plenary Sessions
Case Studies
Track 1: Pharma 4.0™ in Biotechnology Accelerated by Digitalisation
Track 2: Operations Readiness, Technology Transfer and Risk based Case Studies
Track 3: Cell and Gene Therapy Products, ATMPs, Projects, Commercial Manufacturing
Track 4: Cell and Gene Therapy, ATMPs, Data Science Research and Development
Track 6: mABs: Continuous BioManufacturing, Technology Enablers & Rationalisation
Track 5: COVID-19 Vaccines: Development, Manufacturing, Distribution, Vaccination, Impact, Current Situation
Registration
Agile Innovation Life Sciences Development & Manufacturing
Supply Chain, Operations, and Packaging Excellence (SCOPE)
Supply Chain;Operations;and Packaging Excellence (SCOPE)
Concurrent Session
Robotics and Implementation of New Strategies
Implementing and Ensuring Robust Contamination Control
Technical and Process Case Studies during the Pandemic
Executive Forum
Track 1: Sustainability - The Next Challenge
Track 2: Successful Implementation of Annex 1
Track 3 : Reliable Data for Digital Quality
Track 4: Trends in Engineering and Project Management
Site Visits
General Session
Workshop
Digital Transformation
Regulatory & Quality
Supply Chain Optimization
Manufacturing Trends
Therapy Innovations
Instructor-led Training
Track 2: Quality 4.0 • The New Dimension of Quality Through Process and Data Science
Track 1: Annex 1 - Regulatory and Manufacturing Compliance
Track 3: How to Maximise Productivity by Using Closed Systems and Disposables: Annex 1 Implementation Between GXP Compliance and Cost Containment
Track 6: Pharma 4.0 Enabling Technologies
Track 4: Pharma 4.0 Roadmap for Implementation: From Lighthouse Projects and Automation Islands to a Corporate Approach
Track 5: Pharma 4.0 and the Contamination Control Strategy, Environmental Monitoring and Rapid Microbiology Testing
Track 1: Digital Transformation and Pharma 4.0™
Track 2: Bio Manufacturing
Track 4: Emerging Technologies - Part 1
Track 3: Cell & Gene Therapy
Keynotes: Pharma Collaboration
Keynotes: Benefitting from Emerging Technologies

Browse Content
Tracks
Track 1: Digital Transformation and Pharma 4.0™

Track 1: Digital Transformation and Pharma 4.0™

Back

Search Content

Privacy Center

Powered by Conexiant DXP

Categories

Tags

Track 1: Digital Transformation and Pharma 4.0™